Prelude Capital Management, LLC Codexis, Inc. Transaction History

Prelude Capital Management, LLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$1.5 - $3.75 $79,194 - $197,985	52,796 New	52,796 $99,000
Q1 2023 May 15, 2023	SELL	$3.81 - $6.76 $7,833 - $13,898	-2,056 Reduced 10.3%	17,903 $74,000
Q4 2022 Feb 14, 2023	BUY	$4.26 - $6.84 $85,025 - $136,519	19,959 New	19,959 $93,000
Q1 2021 May 17, 2021	SELL	$18.08 - $28.8 $174,688 - $278,265	-9,662 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$11.7 - $23.41 $113,045 - $226,187	9,662 New	9,662 $211,000
Q2 2019 Aug 14, 2019	SELL	$17.0 - $21.88 $433,092 - $557,414	-25,476 Closed	0 $0
Q1 2019 May 15, 2019	SELL	$15.53 - $22.15 $110,728 - $157,929	-7,130 Reduced 21.87%	25,476 $523,000
Q4 2018 Feb 14, 2019	BUY	$14.06 - $22.57 $51,206 - $82,199	3,642 Added 12.57%	32,606 $545,000
Q3 2018 Nov 14, 2018	SELL	$13.35 - $19.1 $307,597 - $440,083	-23,041 Reduced 44.31%	28,964 $497,000
Q2 2018 Aug 14, 2018	BUY	$10.35 - $16.45 $45,446 - $72,231	4,391 Added 9.22%	52,005 $749,000
Q1 2018 May 15, 2018	SELL	$8.0 - $12.8 $10,216 - $16,345	-1,277 Reduced 2.61%	47,614 $524,000
Q4 2017 Feb 14, 2018	BUY	$5.85 - $8.4 $286,012 - $410,684	48,891	48,891 $408,000

125

59.9M

25.9K

20.1K

Ticker CDXS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 65,494,100
Market Cap $335M
Description
Codexis, Inc. discovers, develops, and sells enzymes and other proteins. It offers biocatalyst products and services; intermediate chemicals products that are used for further chemical processing; and Codex biocatalyst panels and kits that enable customers to perform chemistry screening. The company also provides biocatalyst screening and protei...

Get notified when there are updates to the investment portfolio of Prelude Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Prelude Capital Management, LLC with notifications on news.